Form 8-K CONCERT PHARMACEUTICALS, For: Feb 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
Concert Pharma (CNCE) Files $125M Mixed Shelf
March 3, 2015 7:20 AM ESTConcert Pharma (NASDAQ: CNCE) filed to sell up to $125 million worth of mixed securities.
... MoreConcert Pharma (CNCE) Posts Q4 Loss of 36c/Share
February 27, 2015 9:38 AM ESTConcert Pharma (NASDAQ: CNCE) reported Q4 EPS of ($0.36), $0.24 better than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More